ResearcherUniversity of IowaNo recent work listed
Dawn E Quelle
Matched on ORCID iD 0000-0001-8776-0122; OpenAlex author ID A5088413933; NIH RePORTER profile ID 6830020. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 1
- Labs led
- 1
- Collaborators
- 8
2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 grant
Papers 2
- RABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Adenocarcinoma Patients. Last author DOI 10.1177/1947601913501074↗
- The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis. Last author DOI 10.1158/1541-7786.mcr-10-0475↗
Grants 1
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- George J. Weiner · 1 shared grant, 2020 · strength 0.48
- Viviane Palhares Muniz · 2 shared papers, 2011–2013 · strength 0.06
- Paper RABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Ad… DOI 10.1177/1947601913501074↗
- Paper The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ducta… DOI 10.1158/1541-7786.mcr-10-0475↗
- Xuefeng Zhang · 2 shared papers, 2011–2013 · strength 0.06
- Paper RABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Ad… DOI 10.1177/1947601913501074↗
- Paper The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ducta… DOI 10.1158/1541-7786.mcr-10-0475↗
- James J. Mezhir · 1 shared paper, 2013 · strength 0.03
- Bradley D. McDowell · 1 shared paper, 2013 · strength 0.03
- B. J. Smith · 1 shared paper, 2013 · strength 0.03
- Steven R. Grossman · 1 shared paper, 2011 · strength 0.02
- Joseph J. Cullen · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.